Abdul Rahim Anshad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Abdul Rahim Anshad has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Ramendra Pati Pandey
School of Biosciences and Bioengineering, D Y Patil International University, Akurdi, Pune, India
2 shared publications - Sivadoss Raju
State Public Health Laboratory, Directorate of Public Health and Preventive Medicine, Chennai, India
2 shared publications - Aditya P. Dash
Affiliation Asian Institute of Public Health University, Bhubaneswar, Odisha, India
1 shared publication - Ajith B. Kumar
Affiliation State Public Health Laboratory, Directorate of Public Health and Preventive Medicine, DMS Campus, Teynampet, Chennai, Tamil Nadu, India
1 shared publication - Amudhan Murugesan
Department of Microbiology, Government Theni Medical College and Hospital, Theni, India
1 shared publication Anandhazhvar Kumaresan
Affiliation State Public Health Laboratory, Directorate of Public Health and Preventive Medicine, DMS Campus, Teynampet, Chennai, Tamil Nadu, India
1 shared publication
Latest Publications
- Open Access
Intranasal administration of Burkholderia cepacia promotes progressive acute inflammatory changes in experimental BALB/c mice
Burkholderia cepacia ( B. cepacia ) is an opportunistic pathogen with versatile virulence mechanisms. The pathogenesis of B . cepacia in the immunocompetent host following intranasal exposure largely remains ambiguous. Male BALB/c mice were intranasally inoculated with B. cepacia strain 20209 (1×10□ CFU) and evaluated on days 3, 7, 14, and 21 post-infection. Histopathology of lung, liver, spleen, and kidney tissues were performed using H&E and PAS staining. Plasma cytokines were quantified using commercial multiplex assays and ELISA. Matrix metalloproteinase-2 (MMP-2) activity was assessed via gelatin zymography and metabolomic profiling by high-resolution mass spectrometry (HRMS). Histopathological analysis revealed organ-specific pathological indices such as interstitial pneumonitis, bronchitis, leukocyte infiltration, hepatic inflammation, as well as splenic hyperplasia. Similarly, MMP-2 activity revealed time-dependent modulation, reflecting dynamic proteolytic responses. Plasma and tissue IL-18 and IL-1β levels demonstrated a temporal regulation, with IL-18 peaking on day 7 post-infection, while IL-1β showed a biphasic expression peaking on day 3 and 14. Untargeted metabolomics revealed differential expression of lipid metabolism, and energy pathways, with higher expression of phospholipids and sphingolipids. Together, our study portrayed a physiologically relevant intranasal BALB/c model that captures both localized and systemic inflammatory responses to B. cepacia . Our findings highlight organ-specific pathologic progression and sustained inflammation providing key insights into host–pathogen interactions.
Open AccessIntranasal administration of Burkholderia cepacia promotes progressive acute inflammatory changes in experimental BALB/c mice
Burkholderia cepacia ( B. cepacia ) is an opportunistic pathogen with versatile virulence mechanisms. The pathogenesis of B . cepacia in the immunocompetent host following intranasal exposure largely remains ambiguous. Male BALB/c mice were intranasally inoculated with B. cepacia strain 20209 (1×10□ CFU) and evaluated on days 3, 7, 14, and 21 post-infection. Histopathology of lung, liver, spleen, and kidney tissues were performed using H&E and PAS staining. Plasma cytokines were quantified using commercial multiplex assays and ELISA. Matrix metalloproteinase-2 (MMP-2) activity was assessed via gelatin zymography and metabolomic profiling by high-resolution mass spectrometry (HRMS). Histopathological analysis revealed organ-specific pathological indices such as interstitial pneumonitis, bronchitis, leukocyte infiltration, hepatic inflammation, as well as splenic hyperplasia. Similarly, MMP-2 activity revealed time-dependent modulation, reflecting dynamic proteolytic responses. Plasma and tissue IL-18 and IL-1β levels demonstrated a temporal regulation, with IL-18 peaking on day 7 post-infection, while IL-1β showed a biphasic expression peaking on day 3 and 14. Untargeted metabolomics revealed differential expression of lipid metabolism, and energy pathways, with higher expression of phospholipids and sphingolipids. Together, our study portrayed a physiologically relevant intranasal BALB/c model that captures both localized and systemic inflammatory responses to B. cepacia . Our findings highlight organ-specific pathologic progression and sustained inflammation providing key insights into host–pathogen interactions.
- Open Access
- 21 November 2024
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 4 (11) , e0003608
Attrition in serum anti-DENV antibodies correlates with high anti-SARS-CoV-2 IgG levels and low DENV positivity in mosquito vectors—Findings from a state-wide cluster-randomized community-based study in Tamil Nadu, India
The decline in dengue incidence and/or prevalence during the COVID-19 pandemic (2020–22) appears to be attributed to reduced treatment-seeking rates, under-reporting, misdiagnosis, disrupted health services and reduced exposure to mosquito vectors due to prevailing lockdowns. There is limited scientific data on dengue virus (DENV) disease during the COVID-19 pandemic. Here, we conducted a community-based, cross-sectional, cluster-randomized survey to assess anti-DENV and anti-SARS-CoV-2 seroprevalence, and also estimated the spatial distribution of DENV-positive aedine mosquito vectors during the COVID-19 pandemic across all the 38 districts of Tamil Nadu, India. Using real-time PCR, the prevalence of DENV in mosquito pools during 2021 was analyzed and compared with the previous and following years of vector surveillance, and correlated with anti-DENV IgM and IgG levels in the population. Results implicate that both anti-DENV IgM and IgG seroprevalence and DENV positivity in mosquito pools were reduced across all the districts. A total of 13464 mosquito pools and 5577 human serum samples from 186 clusters were collected. Of these, 3.76% of the mosquito pools were positive for DENV. In the human sera, 4.12% were positive for anti-DENV IgM and 6.4% for anti-DENV IgG. While the anti-SARS-CoV-2 levels significantly correlated with overall DENV seropositivity, COVID-19 vaccination status significantly correlated with anti-DENV IgM levels. The study indicates a profound impact of anti-SARS-CoV-2 levels on DENV-positive mosquito pools and seropositivity. Continuous monitoring of anti-DENV antibody levels, especially with the evolving variants of SARS-CoV-2 and the surge in COVID-19 cases will shed light on the distribution, transmission and therapeutic attributes of DENV infection.
- 21 November 2024
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 4 (11) , e0003608
Open AccessAttrition in serum anti-DENV antibodies correlates with high anti-SARS-CoV-2 IgG levels and low DENV positivity in mosquito vectors—Findings from a state-wide cluster-randomized community-based study in Tamil Nadu, India
The decline in dengue incidence and/or prevalence during the COVID-19 pandemic (2020–22) appears to be attributed to reduced treatment-seeking rates, under-reporting, misdiagnosis, disrupted health services and reduced exposure to mosquito vectors due to prevailing lockdowns. There is limited scientific data on dengue virus (DENV) disease during the COVID-19 pandemic. Here, we conducted a community-based, cross-sectional, cluster-randomized survey to assess anti-DENV and anti-SARS-CoV-2 seroprevalence, and also estimated the spatial distribution of DENV-positive aedine mosquito vectors during the COVID-19 pandemic across all the 38 districts of Tamil Nadu, India. Using real-time PCR, the prevalence of DENV in mosquito pools during 2021 was analyzed and compared with the previous and following years of vector surveillance, and correlated with anti-DENV IgM and IgG levels in the population. Results implicate that both anti-DENV IgM and IgG seroprevalence and DENV positivity in mosquito pools were reduced across all the districts. A total of 13464 mosquito pools and 5577 human serum samples from 186 clusters were collected. Of these, 3.76% of the mosquito pools were positive for DENV. In the human sera, 4.12% were positive for anti-DENV IgM and 6.4% for anti-DENV IgG. While the anti-SARS-CoV-2 levels significantly correlated with overall DENV seropositivity, COVID-19 vaccination status significantly correlated with anti-DENV IgM levels. The study indicates a profound impact of anti-SARS-CoV-2 levels on DENV-positive mosquito pools and seropositivity. Continuous monitoring of anti-DENV antibody levels, especially with the evolving variants of SARS-CoV-2 and the surge in COVID-19 cases will shed light on the distribution, transmission and therapeutic attributes of DENV infection.